Learn Before
Informed Consent in Placebo Studies
When utilizing a placebo control condition, researchers must adhere to the ethical principle of informed consent by notifying participants beforehand that they will be assigned to either the genuine treatment or an inactive placebo, even though the exact assignment is concealed until the experiment concludes. Additionally, to ensure ethical fairness, researchers frequently offer the participants who were assigned to the control group the opportunity to receive the actual treatment after the study ends.
0
1
Tags
KPU
Research Methods in Psychology - 4th American Edition @ KPU
Related
Which of the following best describes a placebo control condition in a psychological experiment?
In a research study evaluating a new focus-enhancing herbal tea, match each component of the experimental design to its correct role or description.
A researcher testing a new 'stress-relief' herbal tea gives the experimental group the active tea and the control group a glass of plain water. This design successfully implements a placebo control condition to account for participant expectations.
A researcher is analyzing the results of a study on a new memory supplement to isolate the specific impact of its 'active ingredients.' Based on the logic of using a placebo control condition, arrange the following steps of the analytical process in the correct order.
Informed Consent in Placebo Studies
A placebo control condition is an experimental group in which participants receive a simulated intervention that appears identical to the actual treatment but lacks the active ingredient.
A research team is conducting a study on a new cognitive-behavioral therapy (CBT) workbook. They provide the control group with a simulated workbook that looks professional and requires the same time commitment but contains no therapeutic exercises. Based on the logic of a placebo control condition and the provided diagram, why is it essential that the simulated workbook appears just as 'active' as the real one?
A researcher evaluating a drug study finds that the control group received no treatment at all. The researcher should critique this design because it fails to include a _____, which is necessary to rule out the possibility that any improvement in the treatment group was caused by participant expectations rather than the active ingredient of the drug.
A researcher is designing a study to test a new focus-enhancing herbal tea. Match each element of the experimental design to its corresponding role or term to demonstrate how to isolate the treatment's active ingredients.
An investigator compares a new memory drug against a placebo control condition. If both groups display a 10% improvement in memory scores, the investigator must analyze these results and conclude that the improvement was caused by placebo effects rather than the _____ of the drug.
Arrange the steps a researcher must take to logically evaluate whether a new therapeutic treatment has an effect beyond expectations, starting with the baseline setup.
Learn After
In a study utilizing a placebo control condition, which of the following is an ethical requirement regarding informed consent?
In order to properly maintain experimental concealment, researchers are ethically permitted to wait until the study concludes before informing participants that a placebo condition was used.
A research team is investigating the effects of a new cognitive-behavioral therapy (CBT) program on insomnia. Match each researcher action to the corresponding ethical requirement for informed consent and fairness in this placebo-controlled study.
A team of psychologists is conducting a clinical trial for a new mindfulness app using a placebo-controlled design. To maintain ethical standards, the researchers must follow a specific sequence of actions regarding participant information and treatment access. Arrange the following steps in the correct order to fulfill the requirements of informed consent and ethical fairness.
As a researcher formulating a clinical trial for a new behavioral intervention, you must design a protocol that adheres to the ethical standards for informed consent in placebo studies. Which of the following procedures best synthesizes the requirements for disclosure, concealment, and participant fairness?
A psychologist is designing a clinical trial to test a new therapeutic intervention for social anxiety. To construct an ethically sound study design that synthesizes the requirements for informed consent and fairness in placebo research, which of the following protocols should the researcher implement?
A clinical psychologist is conducting a study to test a new mindfulness-based app for reducing social anxiety against a 'sham' (placebo) app. To adhere to ethical guidelines for informed consent in this placebo study, arrange the following procedural steps in the correct chronological order.
A researcher is designing a placebo-controlled trial for a new psychotherapy technique. Match each component of the informed consent and procedural plan to the specific ethical or methodological function it fulfills.
When utilizing a placebo control condition in a study, what must researchers disclose to participants beforehand to adhere to the ethical principle of informed consent?
In a placebo control study, the ethical principle of informed consent dictates that researchers must reveal whether a participant will receive the genuine treatment or the placebo before the experiment begins.
A researcher completes a study proving that a new behavioral therapy effectively reduces social anxiety compared to a placebo. If the researcher concludes the study without offering the active therapy to the participants who were in the control group, an ethical evaluation would conclude that the researcher failed to uphold the principle of _____.
In a clinical trial where participants have a chance of receiving a placebo, a researcher chooses not to disclose the possibility of an inactive treatment to avoid biasing participants' expectations. An ethics board would evaluate this omission as a violation of _____, which requires that participants be informed of such conditions—including the possibility of placebo assignment—before they agree to participate.